Precise Bio is a regenerative-medicine company that uses a proprietary 4D bio-fabrication platform—combining cell biology, biomaterials, engineering, and laser-assisted printing—to create transplantable human tissues. Initially focused on ophthalmology, its lead program is a lab-grown, bioprinted corneal graft to address the global shortage of donor corneas. The company is also developing other eye-related therapies, such as retinal patches, vision-correction lenticules, and treatments for surface disorders. With facilities in North Carolina and Israel, Precise Bio is building scalable, reproducible manufacturing for bio-printed organs.